Abnormal liver tests (LFTs)
Protocol · GI / Surgical
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Deranged LFTs — classify the pattern, judge magnitude, drive the work-up; spot acute liver failure and cholangitis.
Assessment
Investigations
- R-value = (ALT/ULN)÷(ALP/ULN): ≥5 hepatocellular, ≤2 cholestatic, 2–5 mixed; AST:ALT ≥2 → alcohol
- Baseline: FBC/film, U&E, glucose, INR/coagulation, albumin, split bilirubin
- Hepatocellular: paracetamol level, viral serology, autoimmune (ANA/ASMA/IgG), ferritin, caeruloplasmin (<40y), USS+Doppler
- Cholestatic: RUQ ultrasound first → dilated ducts = extrahepatic (MRCP/EUS/ERCP); non-dilated = intrahepatic (AMA→PBC, MRCP→PSC)
Management
- Acute liver failure (INR ≥1.5 + encephalopathy) → NAC, glucose, hepatology/transplant centre
- Cholangitis (fever+RUQ pain+jaundice) → IV antibiotics + biliary drainage
- Paracetamol / indeterminate ALF → N-acetylcysteine
- ALT/AST >25× ULN → acute viral/toxic; >50× (+high LDH) → ischaemic "shock liver"; >5000 U/L → ischaemic/drug/rhabdo
Disposition
Well + mild rise (<5× ULN) → outpatient work-up (fatty liver, viral, haemochromatosis, alcohol) + recheck. Persistent ALP >2× ULN >6 months or unresolving transaminitis → imaging/biopsy. Isolated raised GGT alone → no liver work-up; isolated bilirubin → fractionate (Gilbert’s/haemolysis).
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.